During the past decade, Policlinico Madonna della Consolazione conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Policlinico Madonna della Consolazione" are "Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Policlinico Madonna della Consolazione" in a lesser frequency.

Most popular intervention types in "Policlinico Madonna della Consolazione" are "Drug" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Rosuvastatin" (1 trials), "Valsartan" (1 trials), "multifactorial continued educational - behavioural programme" (1 trials) and "n-3 PUFA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Madonna della Consolazione" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Madonna della Consolazione". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Policlinico Madonna della Consolazione, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Madonna della Consolazione, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".